Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.
Bernhard MlecnikAlessandro LugliGabriela BindeaFlorence MarliotCarlo BifulcoJiun-Kae Jack LeeInti ZlobecTilman T RauMartin D BergerIris D NagtegaalElisa Vink-BörgerArndt HartmannCarol I GeppertJulie KolwelterSusanne MerkelRobert GrützmannMarc Van den EyndeAnne Jouret-MourinAlex KartheuserDaniel LeonardChristophe RemueJulia WangPrashant BaviMichael H A RoehrlPamela S OhashiLinh T NguyenSeongJun HanHeather L MacGregorSara Hafezi-BakhtiariBradly G WoutersGiuseppe V MasucciEmilia K AnderssonEva ZavadovaMichal VockaJan SpacekLubos PetruzelkaBohuslav KonopasekPavel DundrHelena SkalovaKristýna NěmejcovaGerardo BottiFabiana TatangeloPaolo DelrioGennaro CilibertoMichele MaioLuigi LaghiFabio GrizziTessa FredriksenBénédicte ButtardLucie LafontainePauline MabyAmine MajdiAssia HijaziCarine El SissyAmos KirilovskyAnne BergerChristine LagorceChristopher PaustianCarmen Ballesteros-MerinoJeroen DijkstraCarlijn van de WaterShannon van Lent-van VlietNikki KnijnAna-Maria MușinăDragoș-Viorel ScripcariuBoryana PopivanovaMingli XuTomonobu FujitaShoichi HazamaNobuaki SuzukiHiroaki NaganoKiyotaka OkunoToshihiko TorigoeNoriyuki SatoTomohisa FuruhataIchiro TakemasaPrabhu PatelHemangini H VoraBirva ShahJayendrakumar B PatelKruti N RajvikShashank J PandyaShilin N ShuklaYili WangGuanjun ZhangYutaka KawakamiFrancesco M MarincolaPaolo A AsciertoBernard A FoxFranck PagèsJérôme GalonPublished in: Cancers (2023)
In early CC, low Immunoscore reliably identifies patients at risk of relapse for whom a more intensive surveillance program or adjuvant treatment should be considered.